Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBITDA (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBITDA for 10 consecutive years, with -$73919.0 as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 18.99% to -$73919.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$276136.0, a 10.5% increase, with the full-year FY2025 number at -$283769.0, down 12.3% from a year prior.
  • EBITDA was -$73919.0 for Q4 2025 at Cannabis Suisse, up from -$83474.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $41667.0 in Q1 2022 to a low of -$674320.0 in Q2 2021.
  • A 5-year average of -$91866.8 and a median of -$61907.5 in 2023 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: crashed 4662.15% in 2021, then soared 172.07% in 2022.
  • Cannabis Suisse's EBITDA stood at -$40769.0 in 2021, then soared by 30.55% to -$28314.0 in 2022, then plummeted by 75.32% to -$49641.0 in 2023, then tumbled by 83.82% to -$91248.0 in 2024, then increased by 18.99% to -$73919.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBITDA are -$73919.0 (Q4 2025), -$83474.0 (Q3 2025), and -$53016.0 (Q2 2025).